362 related articles for article (PubMed ID: 19361301)
1. Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents.
Brüggemann RJ; Alffenaar JW; Blijlevens NM; Billaud EM; Kosterink JG; Verweij PE; Burger DM
Clin Infect Dis; 2009 May; 48(10):1441-58. PubMed ID: 19361301
[TBL] [Abstract][Full Text] [Related]
2. Management of drug and food interactions with azole antifungal agents in transplant recipients.
Dodds-Ashley E
Pharmacotherapy; 2010 Aug; 30(8):842-54. PubMed ID: 20653361
[TBL] [Abstract][Full Text] [Related]
3. New generation azole antifungals in clinical investigation.
Girmenia C
Expert Opin Investig Drugs; 2009 Sep; 18(9):1279-95. PubMed ID: 19678798
[TBL] [Abstract][Full Text] [Related]
4. Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions.
Yu DT; Peterson JF; Seger DL; Gerth WC; Bates DW
Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):755-67. PubMed ID: 15654717
[TBL] [Abstract][Full Text] [Related]
5. Differences in interactions between azole drugs related to modifications in the 14-alpha sterol demethylase gene (cyp51A) of Aspergillus fumigatus.
Garcia-Effron G; Mellado E; Gomez-Lopez A; Alcazar-Fuoli L; Cuenca-Estrella M; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2005 May; 49(5):2119-21. PubMed ID: 15855543
[TBL] [Abstract][Full Text] [Related]
6. Second-generation azole antifungal agents.
Kale P; Johnson LB
Drugs Today (Barc); 2005 Feb; 41(2):91-105. PubMed ID: 15821782
[TBL] [Abstract][Full Text] [Related]
7. Drug interactions between nine antifungal agents and drugs metabolized by human cytochromes P450.
Niwa T; Imagawa Y; Yamazaki H
Curr Drug Metab; 2014; 15(7):651-79. PubMed ID: 25429674
[TBL] [Abstract][Full Text] [Related]
8. Introduction to antifungal drugs.
Dismukes WE
Clin Infect Dis; 2000 Apr; 30(4):653-7. PubMed ID: 10770726
[No Abstract] [Full Text] [Related]
9. Overview of antifungal agents.
Thompson GR; Cadena J; Patterson TF
Clin Chest Med; 2009 Jun; 30(2):203-15, v. PubMed ID: 19375628
[TBL] [Abstract][Full Text] [Related]
10. The impact of azole antifungal drugs on imatinib metabolism in human liver microsomes.
Luo X; Li T; Yu Z; Xue X; Zhao H; Li N; Ma L; Yang C; Huang L; Feng W
Xenobiotica; 2019 Jul; 49(7):753-761. PubMed ID: 29770723
[TBL] [Abstract][Full Text] [Related]
11. Azole antimycotics and drug interactions in the perioperative period.
Saari TI; Olkkola KT
Curr Opin Anaesthesiol; 2010 Aug; 23(4):441-8. PubMed ID: 20610983
[TBL] [Abstract][Full Text] [Related]
12. Clinically relevant drug interactions of current antifungal agents.
Gubbins PO; Heldenbrand S
Mycoses; 2010 Mar; 53(2):95-113. PubMed ID: 20002883
[TBL] [Abstract][Full Text] [Related]
13. Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
Harnicar S; Adel N; Jurcic J
J Oncol Pharm Pract; 2009 Sep; 15(3):175-82. PubMed ID: 19282418
[TBL] [Abstract][Full Text] [Related]
14. Update on drug interactions with azole antifungal agents.
Lomaestro BM; Piatek MA
Ann Pharmacother; 1998 Sep; 32(9):915-28. PubMed ID: 9762380
[TBL] [Abstract][Full Text] [Related]
15. Azole antifungals: 35 years of invasive fungal infection management.
Allen D; Wilson D; Drew R; Perfect J
Expert Rev Anti Infect Ther; 2015 Jun; 13(6):787-98. PubMed ID: 25843556
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological considerations for azole antifungal drug management in cystic fibrosis lung transplant patients.
Billaud EM; Guillemain R; Berge M; Amrein C; Lefeuvre S; Louët AL; Boussaud V; Chevalier P
Med Mycol; 2010 Nov; 48 Suppl 1():S52-9. PubMed ID: 21067331
[TBL] [Abstract][Full Text] [Related]
17. Mould-active azoles: pharmacokinetics, drug interactions in neutropenic patients.
Gubbins PO
Curr Opin Infect Dis; 2007 Dec; 20(6):579-86. PubMed ID: 17975407
[TBL] [Abstract][Full Text] [Related]
18. Current and emerging azole antifungal agents.
Sheehan DJ; Hitchcock CA; Sibley CM
Clin Microbiol Rev; 1999 Jan; 12(1):40-79. PubMed ID: 9880474
[TBL] [Abstract][Full Text] [Related]
19. Antifungal agents: mode of action in yeast cells.
Carrillo-Muñoz AJ; Giusiano G; Ezkurra PA; Quindós G
Rev Esp Quimioter; 2006 Jun; 19(2):130-9. PubMed ID: 16964330
[TBL] [Abstract][Full Text] [Related]
20. Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.
Venkatakrishnan K; von Moltke LL; Greenblatt DJ
Clin Pharmacokinet; 2000 Feb; 38(2):111-80. PubMed ID: 10709776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
